Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech
company that leverages advancements in science and technology to
build breakthrough companies that transform human wellness, today
highlighted the continued strength of CannMart Inc.’s (“CannMart”)
in-house cannabis concentrate brand Roilty, the expansion of Rilaxe
Cannabis in multiple provinces across Canada, and the strategic
move to direct-to-retailer distribution in the province of
Saskatchewan.
"As we navigate the competitive landscape of the
cannabis industry, I am pleased to highlight the recent progress of
CannMart including the continued growth of our in-house brand
Roilty and Rilaxe product lines,” said Daniel Stern, CEO of
CannMart. “Roilty's growth in the cannabis concentrate market
underscores our commitment to delivering exceptional products that
resonate with consumers. The strategic expansion of Rilaxe from
dried fruit edibles to include soft-chews and pre-roll blunts
demonstrates our dedication to innovation and addressing diverse
consumer preferences. Our recent strategic move to
direct-to-retailer distribution in Saskatchewan has not only
streamlined our distribution process but will lead to improved
margins. Through the strategic allocation of our marketing and
sales resources we are generating growth in a very competitive line
of business. Our commitment to budtender education, active
engagement, and fostering collaborative relationships with diverse
retail partners is making a difference and critical to achieving
long-term profitability.”
Roilty’s year-over-year growth has been
impressive, starting from a dozen products in June 2022 and growing
to over 35 SKUs by Q3 2023. A large portion of SKU expansion has
been through the Ontario Cannabis Store with multi-pack offerings
in the province's flow-through model selling well above the key
performance indicators set by the province. With 55% market
penetration across Canada and a 10% increase in points of
distribution in the last 30 days, Roilty has captured more market
share in the concentrate category experiencing a 70% year-over-year
increase in units sold for all of Canada, led by Ontario with an
83% increase and Alberta with 56% increase in units sold.(1)
Rilaxe has also experienced substantial growth,
development, and innovation, with expanded offerings tailored to
each province's customer demand and needs. These product
enhancements and expansions have been influenced by real-time
feedback from provincial boards, retailers, and end-use consumers.
Most notably, the addition of Rilaxe Berri Blunts (3 x 0.7G), as a
general list SKU in the fast-growing pre-roll categories, have sold
over 13,000 units since the product launched in January 2023.
Additional success has come from the launch of nostalgic sour-soft
chews: Rilaxe Sour Cherry 1:1 and Rilaxe Sour Peach 1:1 gummies,
which launched in June 2023 and sold through the initial inventory
within the first 2 weeks. With the introduction of new products,
Rilaxe’s store penetration has grown 51% in the last 30
days.(1)
CannMart has expanded its efforts in
Saskatchewan, moving to a direct-to-retailer model creating unique
sales opportunities to leverage a full portfolio of concentrates,
infused pre-rolls and edibles. Owning and managing retailer
relationships, which allows for more control over product launches,
lifecycle management, and inventory controls, create more nimble
pricing and distribution for enhanced customer experience.
(1) Data Source: 3rd party cannabis data and
internal sales data.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic
wellness revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: CannMart, which
operates a B2B wholesale distribution business facilitating
recreational cannabis sales to Canadian provincial government
control boards including for CannMart Labs, a BHO extraction
facility producing high margin cannabis 2.0 products; Australian
Vapes, one of Australia’s largest online retailers of vaporizers
and accessories; and Mikra, a biosciences and consumer wellness
company developing and selling innovative therapies for cellular
health.
Information on Lifeist and its businesses can be
accessed through the links below:
www.lifeist.com https://cannmart.com
https://www.roilty.co https://wearemikra.com/
www.australianvaporizers.com.au
Contact:
Meni Morim, Lifeist Wellness Inc., CEO Ph:
647-362-0390 Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking
information” within the meaning of applicable securities laws. All
statements contained herein that are not historical in nature
contain forward-looking information. Forward-looking information
can be identified by words or phrases such as “may”, “expect”,
“likely”, “should”, “would”, “plan”, “anticipate”, “intend”,
“potential”, “proposed”, “estimate”, “believe” or the negative of
these terms, or other similar words, expressions and grammatical
variations thereof, or statements that certain events or conditions
“may” or “will” happen.
The forward-looking information contained
herein, including, without limitation, statements related to
expectations of improved margins as a result of direct-to-retailer
distribution in Saskatchewan , are made as of the date of this news
release and is based on assumptions management believed to be
reasonable at the time such statements were made, including without
limitation, expectations that the streamlining of its distribution
channel in Saskatchewan will reduce expenses and increase margins.
While we consider these assumptions to be reasonable based on
information currently available to management, there is no
assurance that such expectations will prove to be correct. By its
nature, forward-looking information is subject to inherent risks
and uncertainties that may be general or specific and which give
rise to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct, and that objectives, strategic
goals and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this news release. Such factors
include, without limitation: the failure to realize the expected
benefits from direct-to-retailer distribution in Saskatchewan, and
risks relating to the Company’s ability to execute its business
strategy and the benefits realizable therefrom. Additional risk
factors can also be found in the Company’s current MD&A filed
under the Company’s SEDAR profile at www.sedar.com. Readers are
cautioned not to put undue reliance on forward-looking information.
The Company undertakes no obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable law. Forward-looking statements contained in this news
release are expressly qualified by this cautionary statement.
Source: Lifeist Wellness Inc.
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 4 2024 まで 5 2024
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 5 2023 まで 5 2024